Intralase (NASDAQ:ILSE)
Historical Stock Chart
From Aug 2019 to Aug 2024
![Click Here for more Intralase Charts. Click Here for more Intralase Charts.](/p.php?pid=staticchart&s=N%5EILSE&p=8&t=15)
IntraLase Corp. (Nasdaq:ILSE) today announced that
Shelley B. Thunen, executive vice president and chief financial
officer, will make a presentation to investors and financial analysts
during the Wachovia Securities 16th Annual Nantucket Equity Conference
held in Nantucket, Mass. The presentation is scheduled for Thursday,
June 22 at 9:30 a.m. Eastern.
A live webcast of the audio portion of the presentation will be
available on the Investor Relations News and Events section of the
IntraLase Web site at www.intralase.com. A replay of the webcast will
be available on the IntraLase Web site until June 29, 2006.
About IntraLase Corp.
IntraLase designs, develops, and manufactures an ultra-fast laser
that is revolutionizing refractive and corneal surgery by creating
safe and more precise corneal incisions. Delivering on the promise of
ophthalmic laser technology, the IntraLase FS laser, related software,
and disposable devices replace the hand-held microkeratome blade used
during LASIK surgery. The unsurpassed accuracy of IntraLase's
computer-controlled femtosecond laser has been shown to improve safety
profiles and visual outcomes when used during LASIK. Additionally, the
IntraLase FS laser creates precision-designed intracorneal incisions
that when combined can be used during lamellar and penetrating
keratoplasties, and intrastromal ring implantation. IntraLase is
presently in the process of commercializing applications of its
technology in the treatment of corneal diseases that require corneal
transplant surgery. The company's proprietary laser and disposable
patient interfaces are presently marketed throughout the United States
and 26 other countries. IntraLase has headquarters and manufactures
its products in Irvine. For additional information, visit the
company's Web site: www.intralase.com.